Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone binding	BAZ2A BPTF PHF14 BRD3	1.84e-04	265	22	4	GO:0042393
GeneOntologyMolecularFunction	ATP-dependent activity	MYO15A SMC4 BPTF ATP2B1 DDX46	4.61e-04	614	22	5	GO:0140657
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BAZ2A BRD3	4.95e-04	30	22	2	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BAZ2A BRD3	5.28e-04	31	22	2	GO:0140033
GeneOntologyMolecularFunction	chromatin-protein adaptor activity	BAZ2A PHF14	9.26e-04	41	22	2	GO:0140463
GeneOntologyMolecularFunction	modification-dependent protein binding	BAZ2A BPTF BRD3	1.44e-03	206	22	3	GO:0140030
GeneOntologyMolecularFunction	calmodulin binding	MYO15A PLCB1 ATP2B1	1.98e-03	230	22	3	GO:0005516
GeneOntologyCellularComponent	ISWI-type complex	BAZ2A BPTF	8.68e-05	14	21	2	GO:0031010
GeneOntologyCellularComponent	ribbon synapse	OTOF ATP2B1	4.68e-04	32	21	2	GO:0097470
Domain	Bromodomain_CS	BAZ2A BPTF BRD3	3.13e-06	26	21	3	IPR018359
Domain	DDT	BAZ2A BPTF	7.21e-06	4	21	2	PF02791
Domain	BROMODOMAIN_1	BAZ2A BPTF BRD3	9.29e-06	37	21	3	PS00633
Domain	Bromodomain	BAZ2A BPTF BRD3	1.01e-05	38	21	3	PF00439
Domain	DDT	BAZ2A BPTF	1.20e-05	5	21	2	SM00571
Domain	DDT_dom	BAZ2A BPTF	1.20e-05	5	21	2	IPR018501
Domain	WSD	BAZ2A BPTF	1.20e-05	5	21	2	PF15613
Domain	WHIM1	BAZ2A BPTF	1.20e-05	5	21	2	PF15612
Domain	WHIM1_dom	BAZ2A BPTF	1.20e-05	5	21	2	IPR028942
Domain	WHIM2_dom	BAZ2A BPTF	1.20e-05	5	21	2	IPR028941
Domain	BROMODOMAIN_2	BAZ2A BPTF BRD3	1.27e-05	41	21	3	PS50014
Domain	BROMO	BAZ2A BPTF BRD3	1.37e-05	42	21	3	SM00297
Domain	Bromodomain	BAZ2A BPTF BRD3	1.37e-05	42	21	3	IPR001487
Domain	-	BAZ2A BPTF BRD3	1.37e-05	42	21	3	1.20.920.10
Domain	DDT	BAZ2A BPTF	1.80e-05	6	21	2	PS50827
Domain	PHD	BAZ2A BPTF PHF14	7.85e-05	75	21	3	PF00628
Domain	Znf_PHD-finger	BAZ2A BPTF PHF14	9.17e-05	79	21	3	IPR019787
Domain	PHD	BAZ2A BPTF PHF14	1.31e-04	89	21	3	SM00249
Domain	Znf_PHD	BAZ2A BPTF PHF14	1.40e-04	91	21	3	IPR001965
Domain	ZF_PHD_2	BAZ2A BPTF PHF14	1.59e-04	95	21	3	PS50016
Domain	ZF_PHD_1	BAZ2A BPTF PHF14	1.64e-04	96	21	3	PS01359
Domain	Znf_FYVE_PHD	BAZ2A BPTF PHF14	5.73e-04	147	21	3	IPR011011
Domain	FERM_M	MYO15A FERMT3	1.21e-03	46	21	2	PF00373
Domain	FERM_central	MYO15A FERMT3	1.37e-03	49	21	2	IPR019748
Domain	FERM_1	MYO15A FERMT3	1.43e-03	50	21	2	PS00660
Domain	FERM_2	MYO15A FERMT3	1.43e-03	50	21	2	PS00661
Domain	Band_41_domain	MYO15A FERMT3	1.43e-03	50	21	2	IPR019749
Domain	B41	MYO15A FERMT3	1.43e-03	50	21	2	SM00295
Domain	FERM_3	MYO15A FERMT3	1.43e-03	50	21	2	PS50057
Domain	Zinc_finger_PHD-type_CS	BPTF PHF14	2.40e-03	65	21	2	IPR019786
Domain	C2	PLCB1 OTOF	9.40e-03	131	21	2	PF00168
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PARD3 BAZ2A BPTF PSMD1 PHF14 BRD3 CHAF1A DDX46	1.41e-08	774	22	8	15302935
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MAP1B SMC4 BAZ2A BPTF PSMD1 DDX46 DST	1.06e-07	653	22	7	22586326
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MAP1B SMC4 BPTF ATP2B1 PSMD1 PHF14 BRD3 CHAF1A DST	1.08e-07	1442	22	9	35575683
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PARD3 SMC4 BAZ2A PHF14 BRD3 CHAF1A DDX46 DST TNRC6A	1.48e-07	1497	22	9	31527615
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SMC4 BPTF PHF14 BRD3 CHAF1A TNRC6A	3.62e-07	469	22	6	27634302
Pubmed	Loss-of-function mutations in MYO15A and OTOF cause non-syndromic hearing loss in two Yemeni families.	MYO15A OTOF	3.82e-07	2	22	2	37189200
Pubmed	Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction.	MAP1B DST	3.82e-07	2	22	2	22412020
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	BAZ2A BPTF PHF14 BRD3 CHAF1A DDX46 YAF2 DST	7.21e-07	1294	22	8	30804502
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	PARD3 MAP1B SMC4 BAZ2A BPTF DDX46	9.06e-07	549	22	6	38280479
Pubmed	Identification of novel variants in MYO15A, OTOF, and RDX with hearing loss by next-generation sequencing.	MYO15A OTOF	1.15e-06	3	22	2	31250571
Pubmed	MAP1B and clathrin are novel interacting partners of the giant cyto-linker dystonin.	MAP1B DST	1.15e-06	3	22	2	21936565
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MYO15A SMC4 BPTF PHF14 BRD3 CHAF1A DDX46	2.04e-06	1014	22	7	32416067
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MAP1B SMC4 BPTF ATP2B1 PSMD1 DDX46 DST	2.18e-06	1024	22	7	24711643
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	BAZ2A BPTF PHF14 CHAF1A	2.29e-06	150	22	4	28242625
Pubmed	G-protein-activated phospholipase C-beta, new partners for cell polarity proteins Par3 and Par6.	PARD3 PLCB1	2.29e-06	4	22	2	15782111
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	PARD3 MAP1B SMC4 ATP2B1 PSMD1 DST	3.94e-06	708	22	6	39231216
Pubmed	ABCE1 is a highly conserved RNA silencing suppressor.	MAP1B SMC4 PSMD1 DDX46	7.74e-06	204	22	4	25659154
Pubmed	A human MAP kinase interactome.	PLCB1 PSMD1 CHAF1A DST TNRC6A	1.13e-05	486	22	5	20936779
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PARD3 MAP1B SMC4 BAZ2A ATP2B1 PSMD1 DST	1.35e-05	1353	22	7	29467282
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BAZ2A BPTF BRD3	1.44e-05	75	22	3	25593309
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	SMC4 PSMD1 CHAF1A DDX46 DST	1.84e-05	538	22	5	28524877
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	MAP1B SMC4 PSMD1 DST TNRC6A	1.99e-05	547	22	5	37267103
Pubmed	Expression QTL and regulatory network analysis of microtubule-associated protein tau gene.	BPTF DST	2.09e-05	11	22	2	19233709
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MAP1B BAZ2A BPTF PHF14 CHAF1A DDX46	2.15e-05	954	22	6	36373674
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BAZ2A BPTF PHF14 BRD3 CHAF1A	3.31e-05	608	22	5	36089195
Pubmed	The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila.	MAP1B PSMD1	3.46e-05	14	22	2	21151955
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PHF14 DDX46 DST	3.52e-05	101	22	3	9872452
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	BAZ2A PHF14 BRD3	3.73e-05	103	22	3	32744500
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	PARD3 MAP1B SMC4 PSMD1	4.14e-05	313	22	4	38270169
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	MAP1B SMC4 ATP2B1 PSMD1	4.51e-05	320	22	4	28685749
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PARD3 BAZ2A BPTF BRD3 CHAF1A TNRC6A	5.17e-05	1116	22	6	31753913
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	SMC4 BAZ2A BPTF DDX46	5.78e-05	341	22	4	32971831
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MAP1B PLCB1 PSMD1 DST	6.18e-05	347	22	4	17114649
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	SMC4 BPTF ATP2B1 DST	7.36e-05	363	22	4	14691545
Pubmed	Generation and analysis of 280,000 human expressed sequence tags.	PARD3 PSMD1 CNGA1 DST	7.76e-05	368	22	4	8889549
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	PLCB1 ATP2B1 FERMT3 DST	8.52e-05	377	22	4	38117590
Pubmed	Function of atypical protein kinase C lambda in differentiating photoreceptors is required for proper lamination of mouse retina.	PARD3 CNGA1	9.59e-05	23	22	2	16267237
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	MAP1B SMC4 PHF14 BRD3	1.01e-04	394	22	4	27248496
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	SMC4 BAZ2A CHAF1A DDX46 FERMT3 TNRC6A	1.30e-04	1318	22	6	30463901
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PARD3 PLCB1 ATP2B1 DST	1.30e-04	421	22	4	36976175
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	BAZ2A BPTF YAF2	1.30e-04	157	22	3	30186101
Pubmed	CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.	MAP1B PLCB1 BAZ2A	1.46e-04	163	22	3	23333304
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MAP1B SMC4 BPTF ATP2B1 CHAF1A	1.67e-04	857	22	5	25609649
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	SMC4 BPTF PSMD1	1.92e-04	179	22	3	36261009
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MAP1B SMC4 ATP2B1 PSMD1 DDX46 DST	2.10e-04	1440	22	6	30833792
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	SMC4 BRD3 DDX46	2.47e-04	195	22	3	19454010
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PARD3 MAP1B BPTF ATP2B1 PSMD1 PHF14	2.52e-04	1489	22	6	28611215
Pubmed	Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.	BRD3 CHAF1A	2.94e-04	40	22	2	28805822
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PLCB1 DDX46 DST TNRC6A	3.11e-04	529	22	4	14621295
Pubmed	Proteomic identification of brain proteins that interact with dynein light chain LC8.	PARD3 MAP1B	3.24e-04	42	22	2	14760703
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	PARD3 BPTF ATP2B1 TNRC6A	3.27e-04	536	22	4	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	PARD3 BPTF ATP2B1 TNRC6A	3.32e-04	538	22	4	10512203
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	MAP1B PHF14 DDX46	3.81e-04	226	22	3	31452512
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	PARD3 MAP1B ATP2B1 PSMD1	4.21e-04	573	22	4	28330616
Pubmed	Age-associated alteration of gene expression patterns in mouse oocytes.	SMC4 CHAF1A	4.78e-04	51	22	2	15317747
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MAP1B BPTF BRD3 DDX46 DST	4.89e-04	1082	22	5	38697112
Pubmed	Proteomic analysis of in vivo phosphorylated synaptic proteins.	MAP1B PLCB1	5.16e-04	53	22	2	15572359
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	PARD3 PLCB1 YAF2	6.05e-04	265	22	3	19240061
Interaction	HDAC1 interactions	SMC4 BAZ2A BPTF PSMD1 PHF14 CHAF1A YAF2 DST TNRC6A	1.15e-06	1108	22	9	int:HDAC1
Interaction	CDK2AP1 interactions	BPTF PHF14 BRD3 CHAF1A	7.53e-06	118	22	4	int:CDK2AP1
Interaction	SIRT7 interactions	MAP1B SMC4 BAZ2A BPTF PSMD1 DDX46 DST	9.54e-06	744	22	7	int:SIRT7
Interaction	AFDN interactions	PARD3 ATP2B1 PSMD1 DST TNRC6A	2.50e-05	333	22	5	int:AFDN
Interaction	H2AX interactions	BAZ2A BPTF PHF14 BRD3 CHAF1A YAF2	3.16e-05	593	22	6	int:H2AX
Interaction	CHD4 interactions	SMC4 BAZ2A BPTF PHF14 BRD3 CHAF1A DDX46	4.27e-05	938	22	7	int:CHD4
Interaction	CENPA interactions	BAZ2A BPTF PHF14 BRD3 CHAF1A	4.52e-05	377	22	5	int:CENPA
Interaction	SIN3A interactions	MAP1B SMC4 BPTF CHAF1A DDX46	4.69e-05	380	22	5	int:SIN3A
Interaction	AKR7L interactions	PARD3 DDX46 DST	6.41e-05	72	22	3	int:AKR7L
Interaction	SMARCA5 interactions	SMC4 BAZ2A BPTF BRD3 CHAF1A	7.13e-05	415	22	5	int:SMARCA5
Interaction	GATAD2A interactions	BPTF BRD3 CHAF1A TNRC6A	9.29e-05	224	22	4	int:GATAD2A
Interaction	ARRDC4 interactions	MAP1B SMC4 PSMD1	9.80e-05	83	22	3	int:ARRDC4
Interaction	MACROH2A1 interactions	MAP1B BAZ2A BPTF PHF14 BRD3	1.13e-04	458	22	5	int:MACROH2A1
Interaction	RHOV interactions	PARD3 ATP2B1 PSMD1 DST	1.27e-04	243	22	4	int:RHOV
Interaction	RND1 interactions	PARD3 ATP2B1 PSMD1 DST	1.33e-04	246	22	4	int:RND1
Interaction	PPP6R3 interactions	MAP1B SMC4 PSMD1 CHAF1A	1.60e-04	258	22	4	int:PPP6R3
Interaction	H3C3 interactions	BAZ2A BPTF PHF14 BRD3 CHAF1A	1.63e-04	495	22	5	int:H3C3
Interaction	DIRAS3 interactions	PARD3 ATP2B1 PSMD1 DST	1.70e-04	262	22	4	int:DIRAS3
Interaction	RBBP7 interactions	MAP1B SMC4 BPTF PSMD1 CHAF1A	1.83e-04	507	22	5	int:RBBP7
Interaction	BACC1 interactions	BPTF BRD3 CHAF1A	1.91e-04	104	22	3	int:BACC1
Interaction	RND3 interactions	PARD3 ATP2B1 PSMD1 DST	1.99e-04	273	22	4	int:RND3
Interaction	ARID1A interactions	BPTF BRD3 CHAF1A TNRC6A	2.07e-04	276	22	4	int:ARID1A
Interaction	NSD2 interactions	MAP1B BAZ2A BRD3 DDX46	2.13e-04	278	22	4	int:NSD2
Interaction	H4C9 interactions	BPTF BRD3 CHAF1A	2.14e-04	108	22	3	int:H4C9
Interaction	CBX1 interactions	PHF14 BRD3 CHAF1A YAF2	2.44e-04	288	22	4	int:CBX1
Interaction	HMGXB4 interactions	BPTF BRD3 CHAF1A	2.45e-04	113	22	3	int:HMGXB4
Interaction	H3-3B interactions	BPTF BRD3 CHAF1A	2.51e-04	114	22	3	int:H3-3B
Interaction	KCNA3 interactions	PARD3 MAP1B SMC4 ATP2B1 PSMD1 DST	2.63e-04	871	22	6	int:KCNA3
Interaction	MBD3 interactions	BPTF PSMD1 BRD3 CHAF1A	2.67e-04	295	22	4	int:MBD3
Interaction	PARD3 interactions	PARD3 PLCB1 ATP2B1 DST	2.78e-04	298	22	4	int:PARD3
Interaction	RBBP4 interactions	SMC4 BPTF PHF14 CHAF1A YAF2	3.22e-04	573	22	5	int:RBBP4
Interaction	C11orf52 interactions	PARD3 PLCB1 ATP2B1 DST	3.27e-04	311	22	4	int:C11orf52
Interaction	H2BC8 interactions	BAZ2A BPTF PHF14 BRD3 CHAF1A	3.30e-04	576	22	5	int:H2BC8
Interaction	FBXL6 interactions	MAP1B SMC4 PSMD1 DST TNRC6A	3.49e-04	583	22	5	int:FBXL6
Interaction	XRCC6 interactions	MAP1B BAZ2A BPTF CHAF1A DDX46 YAF2	3.71e-04	928	22	6	int:XRCC6
Interaction	SUMO2 interactions	SMC4 BPTF BRD3 CHAF1A DST	3.71e-04	591	22	5	int:SUMO2
Interaction	PPM1G interactions	MAP1B PHF14 CHAF1A DDX46	3.86e-04	325	22	4	int:PPM1G
Interaction	EML4 interactions	MAP1B SMC4 CHAF1A	4.31e-04	137	22	3	int:EML4
Interaction	ANAPC5 interactions	BRD3 CHAF1A TNRC6A	4.40e-04	138	22	3	int:ANAPC5
Interaction	RUVBL2 interactions	MAP1B SMC4 PSMD1 BRD3 CHAF1A	4.49e-04	616	22	5	int:RUVBL2
Interaction	EPB41L4A interactions	PARD3 ATP2B1 DST	4.59e-04	140	22	3	int:EPB41L4A
Interaction	SMARCD1 interactions	CNGA1 BRD3 CHAF1A TNRC6A	5.05e-04	349	22	4	int:SMARCD1
Interaction	SUZ12 interactions	SMC4 BPTF PHF14 CHAF1A TNRC6A	5.50e-04	644	22	5	int:SUZ12
Interaction	SMC5 interactions	MAP1B BAZ2A BPTF PHF14 CHAF1A DDX46	5.53e-04	1000	22	6	int:SMC5
Interaction	U2AF2 interactions	MAP1B PSMD1 BRD3 DDX46 YAF2	5.77e-04	651	22	5	int:U2AF2
Interaction	CC2D1A interactions	PARD3 MAP1B BRD3	5.83e-04	152	22	3	int:CC2D1A
Interaction	ANAPC1 interactions	PHF14 BRD3 TNRC6A	5.83e-04	152	22	3	int:ANAPC1
Interaction	SMARCB1 interactions	SMC4 BRD3 CHAF1A TNRC6A	5.92e-04	364	22	4	int:SMARCB1
Interaction	CCDC8 interactions	MAP1B SMC4 ATP2B1 PSMD1 DST	5.98e-04	656	22	5	int:CCDC8
Interaction	H2AZ1 interactions	BAZ2A BPTF PHF14 BRD3	6.36e-04	371	22	4	int:H2AZ1
Interaction	CHAF1B interactions	BPTF BRD3 CHAF1A	6.53e-04	158	22	3	int:CHAF1B
Interaction	DUSP15 interactions	SMC4 PSMD1	6.62e-04	35	22	2	int:DUSP15
Interaction	ANAPC7 interactions	MAP1B BRD3 TNRC6A	7.02e-04	162	22	3	int:ANAPC7
Interaction	MKRN2 interactions	PARD3 MAP1B ATP2B1 TNRC6A	7.30e-04	385	22	4	int:MKRN2
Interaction	DDX41 interactions	MAP1B BRD3 CHAF1A	7.53e-04	166	22	3	int:DDX41
Interaction	INO80B interactions	BRD3 DDX46 YAF2	7.67e-04	167	22	3	int:INO80B
Interaction	H2BC21 interactions	MAP1B OTOF BPTF PHF14 CHAF1A	7.82e-04	696	22	5	int:H2BC21
Interaction	ITGB3 interactions	MAP1B PSMD1 FERMT3	8.07e-04	170	22	3	int:ITGB3
Interaction	MTA3 interactions	BPTF BRD3 CHAF1A	8.49e-04	173	22	3	int:MTA3
Interaction	NTRK2 interactions	PARD3 ATP2B1 DST	8.92e-04	176	22	3	int:NTRK2
Interaction	UNK interactions	ATP2B1 BRD3 DST TNRC6A	9.07e-04	408	22	4	int:UNK
Interaction	PSMC3 interactions	PARD3 MAP1B SMC4 PSMD1	1.06e-03	425	22	4	int:PSMC3
Interaction	SMARCA1 interactions	BPTF BRD3 CHAF1A	1.08e-03	188	22	3	int:SMARCA1
Interaction	H3-3A interactions	BAZ2A BPTF PHF14 BRD3 CHAF1A	1.09e-03	749	22	5	int:H3-3A
Interaction	BRD2 interactions	BAZ2A BPTF BRD3 CHAF1A	1.09e-03	429	22	4	int:BRD2
Interaction	ATP1A2 interactions	MAP1B DST	1.09e-03	45	22	2	int:ATP1A2
Interaction	ABCE1 interactions	MAP1B SMC4 PSMD1 DDX46	1.11e-03	431	22	4	int:ABCE1
Interaction	ZNF598 interactions	MAP1B SMC4 ATP2B1 PSMD1	1.15e-03	435	22	4	int:ZNF598
Interaction	RND2 interactions	PARD3 ATP2B1 PSMD1 DST	1.20e-03	440	22	4	int:RND2
Interaction	BPTF interactions	BPTF BRD3 CHAF1A	1.24e-03	197	22	3	int:BPTF
Interaction	PCBD2 interactions	PHF14 CHAF1A	1.24e-03	48	22	2	int:PCBD2
Interaction	H2BC9 interactions	MAP1B OTOF BPTF DST	1.26e-03	446	22	4	int:H2BC9
Interaction	ADNP interactions	MAP1B BRD3 CHAF1A	1.27e-03	199	22	3	int:ADNP
Interaction	ARID4B interactions	BPTF CHAF1A YAF2	1.27e-03	199	22	3	int:ARID4B
Interaction	PRPF8 interactions	MAP1B SMC4 BPTF CHAF1A DDX46	1.27e-03	776	22	5	int:PRPF8
Interaction	MED4 interactions	MAP1B BRD3 DST TNRC6A	1.30e-03	450	22	4	int:MED4
Interaction	IMMT interactions	MAP1B BRD3 CHAF1A DST	1.35e-03	454	22	4	int:IMMT
Interaction	H4C3 interactions	BRD3 CHAF1A	1.35e-03	50	22	2	int:H4C3
Interaction	H2AC19 interactions	PHF14 BRD3	1.35e-03	50	22	2	int:H2AC19
Interaction	TPX2 interactions	BPTF BRD3 DDX46	1.37e-03	204	22	3	int:TPX2
Interaction	SNRNP200 interactions	MAP1B BPTF CHAF1A FERMT3	1.41e-03	460	22	4	int:SNRNP200
Interaction	SEC24C interactions	MAP1B PSMD1 CHAF1A	1.42e-03	207	22	3	int:SEC24C
Interaction	DEK interactions	BPTF PHF14 BRD3	1.46e-03	209	22	3	int:DEK
Interaction	MCAM interactions	PLCB1 ATP2B1 FERMT3 DST	1.51e-03	468	22	4	int:MCAM
Interaction	TXNIP interactions	MAP1B PSMD1 DDX46	1.52e-03	212	22	3	int:TXNIP
Interaction	H4C2 interactions	BRD3 CHAF1A	1.57e-03	54	22	2	int:H4C2
Interaction	ARRDC2 interactions	MAP1B PSMD1	1.57e-03	54	22	2	int:ARRDC2
Interaction	IFI6 interactions	BRD3 DDX46	1.57e-03	54	22	2	int:IFI6
Interaction	H4C12 interactions	BRD3 CHAF1A	1.57e-03	54	22	2	int:H4C12
Interaction	GPS1 interactions	MAP1B SMC4 CHAF1A	1.65e-03	218	22	3	int:GPS1
Interaction	CNOT6 interactions	CHAF1A TNRC6A	1.69e-03	56	22	2	int:CNOT6
GeneFamily	PHD finger proteins	BAZ2A BPTF PHF14	9.22e-05	90	18	3	88
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO15A FERMT3	1.11e-03	50	18	2	1293
GeneFamily	Actins\|Deafness associated genes	MYO15A OTOF	5.55e-03	113	18	2	1152
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PARD3 MAP1B	1.37e-02	181	18	2	694
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PARD3 MAP1B BPTF ATP2B1 PHF14 YAF2 DST	4.29e-06	856	22	7	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	PARD3 MAP1B BPTF ATP2B1 DST	3.57e-05	466	22	5	M13522
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	SMC4 BPTF BRD3	5.75e-05	90	22	3	M39250
Coexpression	BUSSLINGER_GASTRIC_G_CELLS	MAP1B BPTF DST	7.41e-05	98	22	3	M40018
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	SMC4 BPTF ATP2B1 DST	1.05e-04	300	22	4	M8702
Coexpression	IKEDA_MIR30_TARGETS_UP	ATP2B1 DDX46 TNRC6A	1.22e-04	116	22	3	M2379
Coexpression	IKEDA_MIR30_TARGETS_UP	ATP2B1 DDX46 TNRC6A	1.25e-04	117	22	3	MM931
Coexpression	PUJANA_BRCA_CENTERED_NETWORK	SMC4 CHAF1A DDX46	1.29e-04	118	22	3	M15305
Coexpression	ODONNELL_TFRC_TARGETS_DN	BPTF CHAF1A TNRC6A	2.09e-04	139	22	3	M6451
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	PROCA1 RTL5 CNGA1	2.18e-04	141	22	3	M9107
Coexpression	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	SMC4 CHAF1A YAF2	3.39e-04	164	22	3	M13108
Coexpression	PUJANA_XPRSS_INT_NETWORK	SMC4 CHAF1A DDX46	3.64e-04	168	22	3	M18811
Coexpression	BUSSLINGER_GASTRIC_X_CELLS	MAP1B DST TNRC6A	5.30e-04	191	22	3	M40019
Coexpression	GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP	BAZ2A ATP2B1 YAF2	5.88e-04	198	22	3	M8269
Coexpression	ULE_SPLICING_VIA_NOVA2	BPTF ATP2B1	5.95e-04	43	22	2	MM666
Coexpression	ULE_SPLICING_VIA_NOVA2	BPTF ATP2B1	5.95e-04	43	22	2	M1551
Coexpression	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	MYO15A CNGA1 FERMT3	5.97e-04	199	22	3	M8107
Coexpression	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	PLCB1 BPTF CHAF1A	5.97e-04	199	22	3	M6839
Coexpression	GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	CNGA1 BRD3 TNRC6A	5.97e-04	199	22	3	M6314
Coexpression	GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN	BPTF BRD3 YAF2	6.06e-04	200	22	3	M8427
Coexpression	GSE17721_POLYIC_VS_CPG_1H_BMDC_UP	SMC4 YAF2 TNRC6A	6.06e-04	200	22	3	M3934
Coexpression	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN	MYO15A OTOF TNRC6A	6.06e-04	200	22	3	M6185
Coexpression	GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP	BPTF PSMD1 YAF2	6.06e-04	200	22	3	M5763
Coexpression	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP	SMC4 RTL5 YAF2	6.06e-04	200	22	3	M9171
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	BRD3 YAF2 DST	6.06e-04	200	22	3	M5204
Coexpression	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP	BAZ2A CNGA1 BRD3	6.06e-04	200	22	3	M3035
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B BPTF ATP2B1 DST	2.12e-06	190	22	4	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	MAP1B SMC4 PHF14 DDX46	2.45e-06	197	22	4	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	MAP1B ATP2B1 PHF14 DST	2.60e-06	200	22	4	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1\|Striatum / BrainAtlas - Mouse McCarroll V32	PLCB1 OTOF ATP2B1	4.93e-05	146	22	3	7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMC4 CNGA1 FERMT3	5.66e-05	153	22	3	0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PARD3 MAP1B CHAF1A	7.34e-05	167	22	3	805129f887078340b260aa136b0ba19f2bd6ea03
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PARD3 MAP1B CHAF1A	7.34e-05	167	22	3	31cf8bf2eb523f6e7e319620648ff37fc09e2601
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PARD3 MAP1B CHAF1A	7.34e-05	167	22	3	3acb18428d1d33ad430c2fd031b1a91baee3c01d
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP1B PLCB1 DST	7.48e-05	168	22	3	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B ATP2B1 DST	9.63e-05	183	22	3	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	PARD3 MAP1B CNGA1	9.63e-05	183	22	3	273db6a3b00a93ca852498471187b642b5368185
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SMC4 PSMD1 CHAF1A	9.79e-05	184	22	3	7f8488dbb1ee41372cdbcd34a2e14b377218bf0f
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	PARD3 MAP1B PLCB1	9.94e-05	185	22	3	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	BAZ2A BPTF PHF14	9.94e-05	185	22	3	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PARD3 PROCA1 MAP1B	1.01e-04	186	22	3	e52cf44989c57c433bf82e9fa13b4643e88f3577
ToppCell	COVID_vent-Myeloid-Dendritic-cDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	OTOF ATP2B1 DST	1.01e-04	186	22	3	39457a7b43537f2c3e221f9375c95d4515424d7d
ToppCell	droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PARD3 PROCA1 MAP1B	1.01e-04	186	22	3	4c0b59d845b79323e7a3287e7c4d249f5f322556
ToppCell	COVID_vent-Myeloid-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	OTOF ATP2B1 DST	1.01e-04	186	22	3	63a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAP1B ATP2B1 DST	1.03e-04	187	22	3	66ebe1788d51b3e17bec6cdb219f709756b4e530
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Striatum / BrainAtlas - Mouse McCarroll V32	PLCB1 OTOF ATP2B1	1.04e-04	188	22	3	e34ea7014c5a059a7db38f78bd903cf02616ddd3
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B DST TNRC6A	1.09e-04	191	22	3	fd01a206763dfb6d52cca67123571936b4a8e1a0
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B ATP2B1 DST	1.09e-04	191	22	3	219e38df321cd41e2d0861ca01ab0d71bbbd4d9b
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	PLCB1 BPTF TNRC6A	1.11e-04	192	22	3	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	droplet-Pancreas-Endocrine-18m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B DST TNRC6A	1.11e-04	192	22	3	4510aa262da8dcf7c944b3907a51aba5a9397a4e
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B DST TNRC6A	1.11e-04	192	22	3	1304e69c92cef3bd8c82e3c035a7562f5440139a
ToppCell	droplet-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B DST TNRC6A	1.11e-04	192	22	3	0dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	PARD3 PLCB1 TNRC6A	1.13e-04	193	22	3	503a979328c68b096680b71359a26f02fafdff35
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	PLCB1 BPTF TNRC6A	1.13e-04	193	22	3	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	PARD3 MAP1B DST	1.13e-04	193	22	3	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B DST TNRC6A	1.14e-04	194	22	3	92b39a935e8c577eb1123d706d168fa13cf3344c
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B DDX46 DST	1.14e-04	194	22	3	8985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B ATP2B1 DST	1.16e-04	195	22	3	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PLCB1 ATP2B1	1.16e-04	195	22	3	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B ATP2B1 DST	1.16e-04	195	22	3	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PLCB1 ATP2B1	1.18e-04	196	22	3	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PLCB1 ATP2B1	1.22e-04	198	22	3	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	SMC4 BPTF PSMD1	1.22e-04	198	22	3	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PLCB1 ATP2B1	1.22e-04	198	22	3	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PLCB1 ATP2B1	1.22e-04	198	22	3	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PLCB1 ATP2B1	1.22e-04	198	22	3	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	MAP1B BPTF PHF14	1.22e-04	198	22	3	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PLCB1 ATP2B1	1.22e-04	198	22	3	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	BPTF ATP2B1 DST	1.23e-04	199	22	3	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	MAP1B BPTF DST	1.23e-04	199	22	3	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	BPTF ATP2B1 DST	1.23e-04	199	22	3	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Intermediate\|1m / Sample Type, Dataset, Time_group, and Cell type.	MAP1B ATP2B1 PHF14	1.25e-04	200	22	3	805f50236113713b02f77aa5e208efb3b3b959d5
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	MAP1B PLCB1 ATP2B1	1.25e-04	200	22	3	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1B PLCB1 DST	1.25e-04	200	22	3	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B SMC4 PHF14	1.25e-04	200	22	3	38e681997913fcbc93f4e1715820e53844376eab
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	MAP1B PLCB1 DST	1.25e-04	200	22	3	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B PLCB1 DST	1.25e-04	200	22	3	ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	MAP1B ATP2B1 PHF14	1.25e-04	200	22	3	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	MAP1B ATP2B1 PHF14	1.25e-04	200	22	3	c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCell	MS-Multiple_Sclerosis-Others-Platelet\|Multiple_Sclerosis / Disease, condition lineage and cell class	PARD3 MAP1B FERMT3	1.25e-04	200	22	3	263d956136747c209951b4358f2e1672a21d8eef
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ATP2B1 CNGA1	1.35e-03	111	22	2	1847dde68d349114286bc3317be6339666df4aa2
ToppCell	Substantia_nigra-Neuronal-Excitatory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	OTOF ATP2B1	1.52e-03	118	22	2	9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	OTOF RTL5	1.81e-03	129	22	2	e50bd63ad8035abf5135d7d2cb8636206d6e69a5
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MAP1B DST	2.07e-03	138	22	2	8d70e64843f7c3be8ee4203cc126fdf1001f0df5
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B CNGA1	2.16e-03	141	22	2	dcc56aef1b31bfe0de84cb0b5c77d242681cf19c
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	RTL5 TNRC6A	2.28e-03	145	22	2	8b13b576fd2e6e33ccb146860a91a53cee0cdd4d
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYO15A ATP2B1	2.35e-03	147	22	2	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MAP1B DST	2.38e-03	148	22	2	f90ee6fbd71b5e0512af34867202f38409f4de38
ToppCell	Pericytes-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	MAP1B PLCB1	2.44e-03	150	22	2	dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMC4 FERMT3	2.47e-03	151	22	2	75c068b3e3aae5f9ba64d5fa5d1e2105a60e4293
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RTL5 DST	2.60e-03	155	22	2	d76a0f99ec35560d18820f9c92b69364ef2250e3
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RTL5 FERMT3	2.60e-03	155	22	2	b5d5c38b269e9318970fcce564df1c8ed7a7ccc6
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OTOF DST	2.67e-03	157	22	2	e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	OTOF DST	2.70e-03	158	22	2	e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCell	Int-URO-Lymphocyte-T_NK-Treg\|Int-URO / Disease, Lineage and Cell Type	OTOF ANKRD18B	2.70e-03	158	22	2	457d64dceedb67bfff1303334cda1253a839b3d6
ToppCell	COVID-19_Moderate-MAIT\|COVID-19_Moderate / disease group, cell group and cell class	PLCB1 CNGA1	2.74e-03	159	22	2	6d08d670c34eb6bb8ad5dad3293b3107c006236d
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	MAP1B PLCB1	2.77e-03	160	22	2	fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCell	Globus_pallidus-Neuronal-Excitatory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	OTOF ATP2B1	2.77e-03	160	22	2	f843287ed57d2d5a3b3f6dfb03b6934e330e6645
ToppCell	COVID-19_Moderate-MAIT\|World / disease group, cell group and cell class	PLCB1 CNGA1	2.77e-03	160	22	2	bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO15A DST	2.77e-03	160	22	2	0544bc465af208da448858d6e174ff56f2e08a46
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	MAP1B PLCB1	2.80e-03	161	22	2	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PARD3 SMC4	2.80e-03	161	22	2	bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	OTOF ATP2B1	2.80e-03	161	22	2	ebcd5066e82b7760b9da6adc02d11258d1309dab
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	PLCB1 DST	2.80e-03	161	22	2	347edb0de10850b7d16c40945751033289289c9b
ToppCell	droplet-Thymus-nan-21m-Myeloid-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PROCA1 OTOF	2.80e-03	161	22	2	441ebd3c029861d833fbcf8a68fc740d9de8ef2f
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-ILC2\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNGA1 FERMT3	2.80e-03	161	22	2	a3318e738836eb1c5babe1a5d2dd7fa34d732662
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RTL5 FERMT3	2.84e-03	162	22	2	388670cf3acef17df971c0d8ae3ce14398945192
ToppCell	droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO15A RTL5	2.84e-03	162	22	2	8a488ecd25ef41468c3c7766eb936dbc2f7665a9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SMC4 OTOF	2.84e-03	162	22	2	af9999e5fcd28ff1f401d52fd220315752c40027
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RTL5 FERMT3	2.84e-03	162	22	2	9333d923225df7bfdf6b3a4c32816751315aec50
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PLCB1 DST	2.84e-03	162	22	2	373513f9d0e5007b2e10a8b78d4909dcce9e3b62
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAP1B PLCB1	2.87e-03	163	22	2	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP2B1 RTL5	2.91e-03	164	22	2	758e85e2f5e7236b345e16c78344d5e0bf17d8dc
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMC4 FERMT3	2.91e-03	164	22	2	249d8f75a64bce7db52ce0c563f496b9edf602a6
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMC4 CNGA1	2.91e-03	164	22	2	1a9b444d2c6abcc83d4355ec5228b27541df2bd0
ToppCell	droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO15A RTL5	2.91e-03	164	22	2	a67dd181eba275c191f4d0cab13df30eaa3ad913
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RTL5 CNGA1	2.91e-03	164	22	2	b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PARD3 MAP1B	2.94e-03	165	22	2	6799a6580c667738995cceb31cbf1c7fbdc4ff84
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PARD3 MAP1B	2.94e-03	165	22	2	8329d780f244bc31344443b29e5a00529a016662
ToppCell	11.5-Airway-RBC-RBC\|Airway / Age, Tissue, Lineage and Cell class	ANKRD18B FERMT3	2.94e-03	165	22	2	8618b2c5659aa70c7c9d6e51a227ac612b4ad17b
ToppCell	11.5-Airway-RBC\|Airway / Age, Tissue, Lineage and Cell class	ANKRD18B FERMT3	2.94e-03	165	22	2	46042340a373adaf1c439b2301e02fbae3e31a4f
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAP1B PLCB1	2.94e-03	165	22	2	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SMC4 CHAF1A	3.01e-03	167	22	2	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD18B FERMT3	3.01e-03	167	22	2	a813b95c2fafb638b249bc4fa4f708c6f39ad444
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMC4 FERMT3	3.01e-03	167	22	2	eed22d1a17aab84dacb1a488528bae9389644cb9
ToppCell	NS-moderate-d_07-13-Myeloid-pDC\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHAF1A FERMT3	3.05e-03	168	22	2	d03e91f0e0518b33555c0ec98124fc5ed0f11be5
Disease	mean platelet volume	PROCA1 PLCB1 BAZ2A BRD3 FERMT3 TNRC6A	5.84e-05	1020	21	6	EFO_0004584
Disease	Alzheimer disease, age at onset	PARD3 OTOF PHF14 DST	9.18e-05	343	21	4	EFO_0004847, MONDO_0004975
Disease	hypertension, COVID-19	PLCB1 ATP2B1	1.68e-04	27	21	2	EFO_0000537, MONDO_0100096
Disease	non-alcoholic fatty liver disease	PARD3 PLCB1 BPTF	2.83e-04	182	21	3	EFO_0003095
Disease	acute myeloid leukemia (is_marker_for)	PLCB1 FERMT3	5.56e-04	49	21	2	DOID:9119 (is_marker_for)
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO15A OTOF	6.02e-04	51	21	2	cv:CN043650
Disease	reticulocyte count	PROCA1 PLCB1 ATP2B1 BRD3 FERMT3	6.99e-04	1045	21	5	EFO_0007986
Disease	neuroimaging measurement	PARD3 MAP1B PSMD1 CHAF1A TNRC6A	7.75e-04	1069	21	5	EFO_0004346
Disease	Antihypertensive use measurement	PLCB1 ATP2B1 TNRC6A	8.45e-04	265	21	3	EFO_0009927
Disease	Nonsyndromic genetic hearing loss	MYO15A OTOF	1.33e-03	76	21	2	cv:C5680182
Disease	hypothyroidism (biomarker_via_orthology)	MAP1B OTOF	1.47e-03	80	21	2	DOID:1459 (biomarker_via_orthology)
Disease	alcohol consumption measurement	PARD3 MYO15A PLCB1 BRD3 TNRC6A	1.52e-03	1242	21	5	EFO_0007878
Disease	Agents acting on the renin-angiotensin system use measurement	PLCB1 ATP2B1 FERMT3	1.66e-03	335	21	3	EFO_0009931
Disease	hearing impairment	MYO15A OTOF	2.20e-03	98	21	2	C1384666
Disease	immature platelet fraction	BAZ2A BRD3	2.96e-03	114	21	2	EFO_0009187
Disease	Beta blocking agent use measurement	PLCB1 ATP2B1	2.96e-03	114	21	2	EFO_0009929
Disease	immature platelet measurement	BAZ2A BRD3	3.22e-03	119	21	2	EFO_0803541
Disease	t-tau measurement	PARD3 MAP1B	3.60e-03	126	21	2	EFO_0004760
Disease	body fat percentage	BPTF BRD3 TNRC6A	4.79e-03	488	21	3	EFO_0007800
Disease	Hereditary hearing loss and deafness	MYO15A OTOF	4.80e-03	146	21	2	cv:C0236038
Disease	photoreceptor cell layer thickness measurement	MAP1B DST	4.93e-03	148	21	2	EFO_0803370

Protein segments in the cluster

Peptide	Gene	Start	Entry
KEKEKHKVKAEEEKK	BRD3	506	Q15059
KKEKVKMKEKEEVTK	BAZ2A	776	Q9UIF9
KCEKLEKDKKMLEEK	ANKRD18B	796	A2A2Z9
AKKKKEEEKELKEKE	CHAF1A	371	Q13111
KEKVKKKEKKQEEEE	BPTF	986	Q12830
EEEEKKDEKKKEKKN	ATP2B1	296	P20020
KEVKKEEKKEVKKEE	MAP1B	711	P46821
MAKEEDEEKKAKKGK	MYO15A	1	Q9UKN7
KKFKEMEDTIKEKKE	DST	4351	Q03001
EKEKEKEKEKEKEKE	PHF14	116	O94880
KEKEKEKEKEREKEK	PHF14	121	O94880
KEKKKDKDDKEDEKE	DDX46	131	Q7L014
VKKKKEKEKDKEEMD	PROCA1	236	Q8NCQ7
KEEMDEKAKLKKKAK	PROCA1	246	Q8NCQ7
VDVAEEEKEKKKKKK	OTOF	1296	Q9HC10
GKEKKKDRDKEKDKM	PARD3	996	Q8TEW0
KEEEEMKKEEEMKKK	RTL5	376	Q5HYW3
MKKEEEMKKKEEKEE	RTL5	381	Q5HYW3
KKEKEKEKKEEEKME	PSMD1	841	Q99460
KEEKSKDKKEEEKKE	CNGA1	136	P29973
KEKKDKVEKEKSEKE	YAF2	76	Q8IY57
KEKEKEEKKLKEVMD	SMC4	451	Q9NTJ3
EKKEKKKKEKEPEEE	FERMT3	146	Q86UX7
CEKEKKELKKKMDKK	PLCB1	1061	Q9NQ66
QLMEEKKKKKDDKKK	TNRC6A	26	Q8NDV7